A

Aspen Pharmacare Holdings Ltd
JSE:APN

Watchlist Manager
Aspen Pharmacare Holdings Ltd
JSE:APN
Watchlist
Price: 11 255 Zac -0.78% Market Closed
Market Cap: 50.1B Zac

Aspen Pharmacare Holdings Ltd
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Aspen Pharmacare Holdings Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
A
Aspen Pharmacare Holdings Ltd
JSE:APN
Revenue
43.4B
CAGR 3-Years
4%
CAGR 5-Years
5%
CAGR 10-Years
2%
No Stocks Found

Aspen Pharmacare Holdings Ltd
Glance View

Market Cap
50.1B Zac
Industry
Pharmaceuticals

In the vibrant world of global pharmaceuticals, Aspen Pharmacare Holdings Ltd. stands out as a beacon of South African innovation and business acumen. Founded in Durban in 1997, Aspen has grown from modest beginnings into a multinational powerhouse. The company’s core strength lies in manufacturing and producing a diversified portfolio of pharmaceutical products, including generic medications, branded pharmaceuticals, and over-the-counter consumer health products. It further engages in anesthetics, nutritional products, and critical care drugs, offering solutions to myriad health challenges across more than 50 countries. This diversification not only ensures a broad market appeal but effectively hedges against the risks inherent in the pharmaceutical sector, such as patent expirations and regulatory hurdles. Aspen’s financial blueprint is designed around strategic partnerships and manufacturing competencies that serve both developed and emerging markets. It generates revenue primarily through its extensive distribution network and its ability to produce cost-effective generics that address high-demand therapeutic areas, such as cardiovascular, diabetes, and cancer treatments. The company’s growth is fuelled by both organic expansion and astute acquisitions, such as the incorporation of select portfolios from global giants like GlaxoSmithKline. Aspen meticulously balances manufacturing efficiency with stringent regulatory compliance, operated through state-of-the-art facilities accredited by international regulatory bodies. By maintaining this commitment to quality and cost-efficiency, Aspen differentiates itself from competitors and consolidates its position as a significant player in the global pharmaceutical landscape.

APN Intrinsic Value
Not Available
A

See Also

What is Aspen Pharmacare Holdings Ltd's Revenue?
Revenue
43.4B ZAR

Based on the financial report for Jun 30, 2025, Aspen Pharmacare Holdings Ltd's Revenue amounts to 43.4B ZAR.

What is Aspen Pharmacare Holdings Ltd's Revenue growth rate?
Revenue CAGR 10Y
2%

Over the last year, the Revenue growth was -3%. The average annual Revenue growth rates for Aspen Pharmacare Holdings Ltd have been 4% over the past three years , 5% over the past five years , and 2% over the past ten years .

Back to Top